DMII · Drugs Made In America Acquisition II Corp.
The AI's read
The money gives DMII cash now, and another $700,000 remains available. The loan is still a company obligation, and it may turn into shares at a price 35% below the market price after a business combination. The Alpha proposal was accepted in principle, but no final deal is signed. It still needs due diligence, agreements, and approvals. The funding helps DMII, but the debt terms and uncertain proposal leave the company's outlook unchanged.